CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-04 | Ho Carole Chief Medical Officer | Sale | −1,433 | $27.00 | $39K | 113,494 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Option exercise | +5,862 | $5.28 | $31K | 5,862 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −5,262 | $26.27 | $138K | 600 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −600 | $26.81 | $16K | 0 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −8,688 | $26.29 | $228K | 123,982 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −900 | $26.79 | $24K | 123,082 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,862 | 93,751 | ||
| 2019-04-03 | Ho Carole Chief Medical Officer | Option exercise | −5,862 | $5.28 | $31K | 5,862 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −5,262 | $26.27 | $138K | 600 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −600 | $26.81 | $16K | 0 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −8,688 | $26.29 | $228K | 123,982 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Sale | −900 | $26.79 | $24K | 123,082 |
| 2019-04-03 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −5,862 | 93,858 | ||
| 2019-04-03 | Watts Ryan J. President and CEO | Sale | −5,641 | $26.28 | $148K | 2,598,138 |
| 2019-04-03 | Watts Ryan J. President and CEO | Sale | −500 | $26.77 | $13K | 2,597,638 |
| 2019-04-02 | Ho Carole Chief Medical Officer | Option exercise | +6,242 | $5.28 | $33K | 6,242 |
| 2019-04-02 | Ho Carole Chief Medical Officer | Sale | −2,800 | $24.51 | $69K | 3,442 |
| 2019-04-02 | Ho Carole Chief Medical Officer | Sale | −3,442 | $25.15 | $87K | 0 |
| 2019-04-02 | Ho Carole Chief Medical Officer | Sale | −9,445 | $25.29 | $239K | 132,670 |
| 2019-04-02 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −6,242 | 99,613 |
Page 40 of 53 · 1,053 trades